Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

LA JOLLA PHARM. RAISES $14 MILLION

Feb. 5, 1992

ATRIX TO DELAY PERIODONTAL DRUG NDA

Feb. 5, 1992

ANALYSTS RAISE AMGEN ESTIMATES

Feb. 5, 1992

AMERICAN BIOGENETIC TO REDEEM WARRANTS

Feb. 4, 1992

MGI RETAINS FAITH IN CHEMOPROTECTIVES

Feb. 4, 1992

CELLCOR FILES FOR 2 MILLION-SHARE IPO

Feb. 4, 1992

ANALYST RAISES ESTIMATE FOR BIOMIRA

Feb. 4, 1992

ATS, MEDISORB MESH TECHNOLOGIES

Feb. 4, 1992

ENZO SHAREHOLDERS TENDER DEBENTURES

Feb. 4, 1992

VIMRX REVISES DOSING SCHEDULE

Feb. 4, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...